BRIDGEWATER, N.J. , May 27, 2026 /PRNewswire/ --Â Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform...
Insmed (NASDAQ:INSM) Chair and CEO Will Lewis said the company remains confident in the launch trajectory of BRINSUPRI, despite investor concerns over discontinuation rates that followed the company’s...
June S&P 500 E-Mini futures (ESM26) are trending up +0.46% this morning as investors shrugged off an exchange of fire between the U.S. and Iran and awaited the release of the key U.S. jobs report.
Insmed (NASDAQ:INSM) executives said the company entered 2026 with strong commercial momentum for BRINSUPRI and continued growth for ARIKAYCE, while advancing late-stage development of TPIP across multiple...
The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -0.38%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.12%. June...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.40%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.28%. Equity markets retreated...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.05%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.20%. June E-mini S&P futures (ESM26...
— Total Company Revenues of $306.0 Million for the First Quarter of 2026—
Barchart Research What to Expect from INSM Earnings INSM Generated May 6, 2026 Current Price $137.09 EPS Estimate $$-0.90 Consensus Rating Strong Buy Average Move 4.46% Insmed's Path to Profitability Faces...